Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,073	2,489	1,792	1,936	698	346
Market Cap Growth	13.69%	38.90%	-7.42%	177.28%	101.66%	-10.41%
Enterprise Value	2,386	2,050	1,675	1,684	528	219
Last Close Price	25.00	20.87	16.81	18.60	6.77	3.34
PE Ratio	14.63	15.19	25.10	23.30	17.68	4.62
Forward PE	15.52	15.38	14.13	14.98	13.97	8.97
PS Ratio	5.26	5.06	4.50	9.04	4.96	2.91
PB Ratio	3.35	3.42	4.62	6.44	3.38	2.04
P/TBV Ratio	3.88	4.36	9.25	7.22	3.38	2.04
P/FCF Ratio	13.10	10.40	-	18.26	11.76	7.69
P/OCF Ratio	13.09	10.38	12.48	16.68	11.56	7.69
EV/Sales Ratio	4.13	4.17	4.21	7.86	3.75	1.84
EV/EBITDA Ratio	8.04	8.80	13.99	16.33	10.03	5.30
EV/EBIT Ratio	9.22	10.51	19.29	16.53	10.07	5.31
EV/FCF Ratio	10.17	8.57	-	15.88	8.89	4.87
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.02	0
Debt / EBITDA Ratio	0.01	0.01	0.03	0.04	0.08	0.00
Debt / FCF Ratio	0.01	0.01	-	0.04	0.07	0.00
Asset Turnover	0.63	0.74	0.94	0.70	0.66	0.78
Inventory Turnover	4.06	4.63	12.93	7.38	6.20	10.15
Quick Ratio	6.19	4.83	2.52	5.37	7.32	6.45
Current Ratio	6.62	5.17	2.88	5.57	7.76	7.00
Return on Equity (ROE)	27.52%	29.38%	20.75%	32.76%	20.98%	58.30%
Return on Assets (ROA)	17.74%	18.46%	12.83%	20.75%	15.22%	16.94%
Return on Invested Capital (ROIC)	89.65%	63.32%	50.51%	629.06%	159.91%	352.89%
Return on Capital Employed (ROCE)	28.00%	26.70%	22.00%	32.00%	24.90%	24.40%
Earnings Yield	7.08%	6.58%	3.98%	4.29%	5.66%	21.66%
FCF Yield	7.63%	9.61%	-3.06%	5.48%	8.50%	13.00%
Buyback Yield / Dilution	-4.21%	-9.84%	-2.14%	-3.32%	-1.46%	-0.21%

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q